El-Hibri Fuad Blog

Archive for the ‘Emergent BioSolutions’ Category

ROCKVILLE, MD, May 13, 2010 – Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has been named Biotechnology Firm of the Year at the Tech Council of Maryland’s (TCM) Annual Tech Awards.  This award acknowledges the company that best exemplifies the spirit of Maryland’s biotechnology community as well as its presence and leadership within the [...]

ROCKVILLE, Md., Mar 11, 2010 (BUSINESS WIRE) — Emergent BioSolutions Inc. (EBS 15.96, -0.03, -0.19%) announced today that Fuad El-Hibri, its chairman and chief executive officer, has been named by the World Trade Center Institute (WTCI) as one of Maryland’s outstanding international business leaders. Celebrating the spirit of global ambition and excellence in international leadership, [...]

500 Most Influential Muslims: Science and Technology

Posted by: fuadelhibri on: January 6, 2010

The Prince Alwaleed Bin Talaal Center for Muslim-Christian Understanding and The Royal Islamic Strategic Studies Centre published its first edition in what promises to be an annual series of insight into the movers and shakers of the Muslim world. Entitled The 500 Most Influential Muslims 2009, the book categorizes Muslims’ influential capacities into 15 categories: [...]

Fuad el-Hibri, king of anthrax, wins an award from Ernst & Young

Posted by: fuadelhibri on: December 16, 2009

Marie-José Daoud Awarded the Ernst and Young prize for Entrepreneur of the year 2009 in the Technology category for the Greater Washington region last June, Fuad El-Hibri is the CEO of Emergent Biosolutions, an American company that supplies the anthrax vaccine to the American government. He is in line for the national E&Y 2009 prize, [...]

By Nihad Tobalian Lebanese businessman Fuad El-Hibri is the “Entrepreneur of the Year for 2009” for the Washington, DC area, and earned this award from Ernst & Young’s Global Technology Group, which is given to honor businessmen who lead nascent companies to growth in their specialized area of work. He earned this award for leading [...]

BioPort is the only FDA-licensed producer of the anthrax vaccine. Fuad El-Hibri, chairman and CEO of Emergent BioSolutions Inc., speaks March 9 in Sage Hall. Kevin Stearns/University Photography On March 9, MBA students taking International Political Risk Management, a course taught by Elena Iankova, a lecturer at the S.C. Johnson Graduate School of Management, heard [...]

CEO & Chairman, 10% Owner of Emergent BioSolutions Inc. (EBS) Fuad El-hibri sells 15,000 shares of EBS on 08/11/2009 at an average price of $16.78 a share. EMERGENT BIOSULUTIONS INC. is a leading biopharmaceutical company dedicated to one simple mission – to protect life. EBS develops manufactures and commercializes vaccines and therapeutics that assist the [...]

Emergent BioSolutions Inc., Q2 2009 Earnings Call Transcript

Posted by: fuadelhibri on: August 17, 2009

Emergent BioSolutions Inc., (EBS) Q2 2009 Earnings Call August 6, 2009 5:00 pm ET Executives Robert G. Burrows – Vice President, Investor Relations Fuad El-Hibri – Chairman of the Board, Chief Executive Officer R. Don Elsey – Chief Financial Officer Daniel J. Abdun-Nabi – President, Chief Operating Officer W. James Jackson, Ph.D. – Senior Vice [...]

Fuad El-Hibri on Vox

Posted by: fuadelhibri on: August 17, 2009

Mr. Fuad El-Hibri is the Chairman and Chief Executive Officer of Emergent BioSolutions Inc. (Emergent) family, health, polo, music, telecommunications, telecom, science, technology, banking, mergers, acquisitions, management, academia

ROCKVILLE, MD, September 26, 2007—Emergent BioSolutions Inc. (NYSE: EBS), announced today that it has signed a three year contract with the U.S. Department of Health and Human Services (HHS), with a total value of up to $448 million.  Components of the contract include: $400 million firm fixed-price for delivery of 18.75 million doses of BioThrax® [...]


Follow

Get every new post delivered to your Inbox.